The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Baxalta; Baxter; Bayer (Inst); Celgene; Celgene (Inst); Genentech (Inst); Hallozyme (Inst); Immunomedics (Inst); Incyte; Ipsen; Lilly; Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); QED Therapeutics; Roche; Sanofi; SERVIER; Shire
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
A randomized phase II study of second-line treatment with liposomal irinotecan, and S-1 versus liposomal irinotecan and 5-fluorouracil in gemcitabine-refractory metastatic pancreatic cancer patients.
 
Esther Pijnappel
No Relationships to Disclose
 
Judith de Vos-Geelen
Research Funding - SERVIER (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Teresa Macarulla Mercade
No Relationships to Disclose
 
Davide Melisi
Consulting or Advisory Role - Baxter; Evotec; Incyte; iOncologi; Lilly; Shire
Research Funding - Celgene; Evotec; Incyte; iOncologi; Shire
 
Per Pfeiffer
Research Funding - Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Nordic Drugs; Pfizer; PledPharma; Roche; SERVIER; Taiho Pharmaceutical
 
Gerald W. Prager
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Honoraria - Lilly/ImClone
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Johanna Wilmink
Consulting or Advisory Role - Celgene; SERVIER
Speakers' Bureau - Medscape
Research Funding - AstraZeneca (Inst); Celgene; Merck (Inst); Novartis; Pfizer/EMD Serono (Inst); Roche (Inst); SERVIER